Stabilised Spike Protein

Lab Reagents

Human IgG antibody Laboratories manufactures the stabilised spike protein reagents distributed by Genprice. The Stabilised Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Stabilised products are available in stock. Specificity: Stabilised Category: Spike Group: Protein

Protein information

Sucrose Brix Std Stabilised 15% at 20C

BS15S 15ML
EUR 78.66

Sucrose Brix Std Stabilised 19.4% at 20C

BS194S 15ML
EUR 76.38

Sucrose Brix Std Stabilised 20% at 20C

BS20S 15ML
EUR 78.66

Sucrose Brix Std Stabilised 23.8% at 20C

BS238S 15ML
EUR 76.38

Sucrose Brix Std Stabilised 25% at 20C

BS25S 15ML
EUR 495.9

Sucrose Brix Std Stabilised 30% at 20C

BS30S 15ML
EUR 78.66

Sucrose Brix Std Stabilised 35% at 20C

BS35S 15ML
EUR 144.78

Sucrose Brix Std Stabilised 40% at 20C

BS40S 15ML
EUR 78.66

Sucrose Brix Std Stabilised 45% at 20C

BS45S 15ML
EUR 78.66

Sucrose Brix Std Stabilised 50% at 20C

BS50S 15ML
EUR 78.66

Sucrose Brix Std Stabilised 55% at 20C

BS55S 15ML
EUR 78.66

Sucrose Brix Std Stabilised 67.5% at 20C

BS67S 15ML
EUR 78.66

SARS Spike RBD Recombinant Protein

10-211 0.1 mg
EUR 651.3
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.

MERS Spike S1 Recombinant protein

39-102 0.1 mg
EUR 556.8
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis.

SARS-CoV spike protein Antibody

abx023139-100ug 100 ug
EUR 1028.4

SARS-CoV spike protein Antibody

abx023143-100ug 100 ug
EUR 1028.4

SARS Spike Peptide

3219P 0.05 mg
EUR 197.7
Description: (NT) SARS Spike peptide